| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |